ISB News

ISB In the News: NIH, Viral Networks and Systems Biology

LiveScience Going Viral: When Living Networks Go Awry. Story from NIH about systems biology and networks.

Emily Carlson and Sharon Reynolds, of the National Institutes of Health/NIGMS, posted a story on NIGMS's Inside Life Science as well as on Livescience.com on how systems biology is a powerful approach to studying biological networks. The article included comments from ISB scientist Aaron Brooks and senior research engineer Chris Lausted who created a network activity that they presented during the USA Science & Engineering Festival in Washington D.C. on April 26-27. The project was supported by funding through ISB's Center for Systems Biology and NIH/NIGMS.

"(Networks) can yield information that helps us better understand — and potentially influence — complex phenomena that affect our health."

The network diagram above — by Allison Kudla, ISB's communication designer — depicts yeast cells (superimposed circles) and the biochemical "chatter" between them (lines) that tells the cells to gather together in clumps. This clumping helps them survive stressful conditions like a shortage of nutrients.

Read the article

NIH NIGMS story about ISB's systems biology and studying biological networks.

Recent Articles

  • Dr. Sean Gibbons Promoted to Associate Professor

    Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor. “Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new…

  • AmeriCorps Member Sara Calder Joins ISB as Systems Health and STEM Coordinator

    Sara Calder recently joined ISB as Systems Health and STEM Coordinator, and is our second-ever AmeriCorps member. In this Q&A, Calder shares her education journey, her future plans, and much more.

  • In First-of-Its-Kind Trial, Scientists Use CRISPR to Treat Cancer

    Scientists for the first time have used CRISPR to substitute a gene to treat patients with cancer. The remarkable findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.